A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound

Overview

About this study

A study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Community-dwelling adult individuals

Inclusion Criteria:

  • Adult patients (>30 years of age, with pre-specified subgroups 30-64 and 65+))

 Exclusion Criteria: 

  • Inability to provide informed consent to participate in the study

Adult females (≥ 18 years of age) that are currently pregnant

Inclusion Criteria:

  • Adult female aged 18 to 49 years 

  • Pregnant at the time of enrollment

  • Receiving obstetric care at identified study site(s) 

  • Willing and able to provide informed consent 

 Exclusion Criteria:

  • Inability to provide consent

Adolescents and young adults

Inclusion Criteria:

  • Enrollment in a high-school, college or a resident in MN during the study period.

  • Age 15–29 years

  • Informed consent (and assent for minors).

Exclusion Criteria:

  • Presence of a pacemaker or defibrillator.

  • Inability to obtain a quality ECG tracing.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/24/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Paul Friedman

Open for enrollment

Contact information:

Amanda Priebe

(507) 422-6932

priebe.amanda@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597371

Mayo Clinic Footer